Videos

Vibeke Strand, MD, on Immunogenicity in Immune-Mediated Inflammatory Diseases

12/26/2019

In this video, Vibeke Strand, MD, discusses immunogenicity and its contributing factors among individuals with immune-mediated inflammatory diseases, the role of therapeutic drug monitoring in a rheumatology setting, and more.

Vibeke Strand, MD, is a clinical rheumatologist in California, as well as a biopharmaceutical consultant.

Published in partnership with

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Videos

Joshua Baker, MD, on the Risk of Diabetes Among Patients With RA

07/29/2021

In this video, Dr Joshua Baker, an assistant professor of rheumatology and epidemiology at the University of Pennsylvania, discusses the risk of diabetes among patients with rheumatoid arthritis.

In this video, Dr Joshua Baker,...

07/29/2021

Rheumatology & Arthritis

Videos

Trials in Rheumatology: IL-6 and Beyond

02/08/2021

In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here. Additional Resource:

In this video, Leonard...

02/08/2021

Rheumatology & Arthritis

Videos

A Preview of the ACR Guideline for the Management of JIA

12/01/2020

The American College of Rheumatology (ACR) guideline for the management of juvenile idiopathic arthritis (JIA) is currently under review and will soon be published. In this video, the lead investigator of the guideline’s Core Team, Karen...

The American College of...

12/01/2020

Rheumatology & Arthritis

FDA Approves Treatment Option for Polyarticular Course JIA

10/01/2020

The US Food and Drug Administration (FDA) has approved Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) among pediatric patients aged 2 years or older. The...

The US...

10/01/2020

Rheumatology & Arthritis

Which Patients With Psoriasis Are More Likely to Develop PsA?

06/26/2020

Patients with psoriasis who also have structural entheseal lesions, even when they have no clinical symptoms of musculoskeletal disease, are at a higher risk of developing psoriatic arthritis (PsA) than patients...

Patients...

06/26/2020

Rheumatology & Arthritis

Vibeke Strand, MD, on Immunogenicity in Immune-Mediated Inflammatory Diseases

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products